XPH — State Street SPDR S&P Pharmaceuticals ETF price, holdings and performance
State Street SPDR S&P Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETF (AMEX: XPH) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.
| Category | - | Asset Type | Equity | Tags | healthcare | Return% 1Y | 66.67% | Total Holdings | 65 | Perf Week | 3.61% |
| Sponsor | SPDR | ETF Type | Tags | sector | Return% 3Y | 19.17% | AUM | $513.03M | Perf Month | 0.67% | |
| Fund Family | Bond Type | Tags | - | Return% 5Y | 8.04% | NAV/sh | Perf Quarter | 18.04% | |||
| Index | - | Average Maturity | Tags | - | Return% 10Y | 52W High | 70.71 -0.86% | Perf Half Y | 26.68% | ||
| Index Weighting | Commodity Type | Tags | - | Return% SI | 52W Low | 41.72 68.02% | Perf YTD | 25.91% | |||
| Active/Passive | Quant Type | Tags | - | Flows% 1M | 0.00% | Volatility | 1.85% 2.17% | Perf Year | 68.23% | ||
| Dividend TTM | 0.34 (0.48%) | ESG Type | Tags | - | Flows% 3M | 0.41% | ATR (14) | 1.48 | Perf 3Y | 64.08% | |
| Dividend Ex-Date | Jun 22, 2026 | Dividend Type | Sector/Theme | Flows% YTD | 2.54% | RSI (14) | 63.63 | Perf 5Y | 40.09% | ||
| Dividend Gr. 3/5Y | - | Structure Type | Region | Flows% 1Y | Beta | 0.59 | Perf 10Y | 53.27% | |||
| Expense | 0.35% | Growth/Value | SMA20 | 2.87% | Flows% 3Y | Rel Volume | 1.27 | Prev Close | 70.52 | ||
| Inverse/Leveraged | Market Cap | SMA50 | 8.88% | Flows% 5Y | Avg Volume | 89.30K | Price | 70.11 | |||
| IPO Date | Jun 19, 2006 | Option/Short | Yes / Yes | SMA200 | 22.42% | 52W Range % | 98% | Volume | 113,222 | Change | -0.59% |
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.
Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.